UBS Group’s Rayliant NxtGen Multifactor US Equity ETF RWLC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-330
Closed -$10.5K 10937
2026
Q1
$10.5K Buy
330
+300
+1,000% +$9.92K ﹤0.01% 8357
2025
Q4
$996 Buy
+30
New +$1.13K ﹤0.01% 9735
2025
Q3
Sell
-248
Closed -$8.91K 10821
2025
Q2
$8.91K Sell
248
-463
-65% -$15.5K ﹤0.01% 8919
2025
Q1
$23.1K Buy
711
+621
+690% +$20.4K ﹤0.01% 8128
2024
Q4
$2.85K Hold
90
﹤0.01% 8976
2024
Q3
$2.78K Sell
90
-60
-40% -$1.78K ﹤0.01% 8367
2024
Q2
$4.42K Buy
+150
New +$4.25K ﹤0.01% 8097
2022
Q4
Sell
-922
Closed -$19K 11063
2022
Q3
$19K Buy
922
+900
+4,091% +$19.9K ﹤0.01% 7469
2022
Q2
$0 Buy
+22
New +$500 ﹤0.01% 10814

Other funds holding RWLC

UBS Group's RWLC Position: Q2 2026 in Review

UBS Group sold out of Rayliant NxtGen Multifactor US Equity ETF (RWLC) in Q2 2026, closing a stake of 330 shares — an estimated $10.5K sold.

UBS Group first reported a position in RWLC in Q2 2022 and held it in 9 quarters. The position peaked at $23.1K in Q1 2025. 8 funds tracked by Wall St. Rank hold RWLC as of Q2 2026.

  • UBS Group reported no remaining Rayliant NxtGen Multifactor US Equity ETF position as of Q2 2026 after selling out during the quarter.
  • UBS Group sold 330 Rayliant NxtGen Multifactor US Equity ETF shares in Q2 2026, an estimated $10.5K.
  • UBS Group first reported a position in Rayliant NxtGen Multifactor US Equity ETF in Q2 2022 and held it in 9 quarters.
  • UBS Group's Rayliant NxtGen Multifactor US Equity ETF position peaked at $23.1K in Q1 2025.
  • 8 funds tracked by Wall St. Rank held Rayliant NxtGen Multifactor US Equity ETF as of Q2 2026.

Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.